Haplotypes across ACE and the risk of Alzheimer's disease: The three-city study

Journal of Alzheimer's Disease

Volumn 13, Issue 3, 2008, Pages 333-339

  Bruandet, Amélie ^a,b,c   Richard, Florence ^a,b,c   Tzourio, Christophe ^b,d   Berr, Claudine ^b,e   Dartigues, Jean François ^b,f   Alpérovitch, Annick ^b   Amouyel, Philippe ^a,b,c   Helbecque, Nicole ^a,b,c  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSERM   (France)

^c UNIV LILLE   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIV MONTPELLIER   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Alzheimer's disease; Case control study; Genetics; Polymorphism; Risk factors

Indexed keywords

ACE GENE; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; GENE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 47849121954     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-13310     Document Type: Article

References (34)

1. 3C Study Group, Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology 22 (2003), 316-325.
2. P. Amouyel, F. Richard, D. Cottel, C. Amant, V. Codron and N. Helbecque, The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment, Neurosci Lett 217 (1996), 203-205.
3. M.M. Breteler, Vascular risk factors for Alzheimer's disease: an epidemiologic perspective, Neurobiol Aging 21 (2000), 153-160.
4. D. Commenges, M. Gagnon, L. Letenneur, J.F. Dartigues, P. Barberger-Gateau and R. Salamon, Improving screening for dementia in the elderly using, Mini-Mental State Examination subscores, Benton's Visual Retention Test, and Isaacs' Set Test, Epidemiology 3 (1992), 185-188.
5. O. Costerousse, J. Allegrini, M. Lopez and F. Alhenc-Gelas, Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes, Biochem J 290 (1993), 33-40.
6. E.A. Eckman, S.K. Adams, F.J. Troendle, B.A. Stodola, M.A. Kahn, A.H. Fauq, H.D. Xiao, K.E. Bernstein and C.B. Eckman, Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme, J Biol Chem 281 (2006), 30471-30478.
7. J.S. Elkins, V.C. Douglas and S.C. Johnston, Alzheimer disease risk and genetic variation in ACE: a meta-analysis, Neurology 62 (2004), 363-368.
8. M.L. Hemming and D.J. Selkoe, Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor, J Biol Chem 280 (2005), 37644-37650.
9. M.L. Hemming, D.J. Selkoe and W. Farris, Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease, Neurobiol Dis 26 (2007), 273-281.
10. W.G. Hill, Estimation of linkage disequilibrium in randomly mating populations, Heredity 33 (1974), 229-239.
11. J. Hu, A. Igarashi, M. Kamata and H. Nakagawa, Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity, J Biol Chem 276 (2001), 47863-47868.
12. K.A. Jellinger, Pathology and pathophysiology of vascular cognitive impairment. A critical update, Panminerva Med 46 (2004), 217-226.
13. K.A. Jellinger, Understanding the pathology of vascular cognitive impairment 159, J Neurol Sci 229-230 (2005), 57-63.
14. H. Katzov, A.M. Bennet, P. Kehoe, B. Wiman, M. Gatz, K. Blennow, B. Lenhard, N.L. Pedersen, U. de Faire and J.A. Prince, A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity, Hum Mol Genet 13 (2004), 2647-2657.
15. B. Keavney, C.A. McKenzie, J.M. Connell, C. Julier, P.J. Ratcliffe, E. Sobel, M. Lathrop and M. Farrall, Measured haplotype analysis of the angiotensin-I converting enzyme gene, Hum Mol Genet 7 (1998), 1745-1751.
16. P.G. Kehoe, H. Katzov, L. Feuk, A.M. Bennet, B. Johansson, B. Wiman, U. de Faire, N.J. Cairns, G.K. Wilcock, A.J. Brookes, K. Blennow and J.A. Prince, Haplotypes extending across ACE are associated with Alzheimer's disease, Hum Mol Genet 12 (2003), 859-867.
17. D.J. Lehmann, M. Cortina-Borja, D.R. Warden, A.D. Smith, K. Sleegers, J.A. Prince, C.M. van Duijn and P.G. Kehoe, Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease, Am J Epidemiol 162 (2005), 305-317.
18. C.L. Lendon, U. Thaker, J.M. Harris, A.M. McDonagh, J.C. Lambert, M.C. Chartier-Harlin, T. Iwatsubo, S.M. Pickering-Brown and D.M. Mann, The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease, Neurosci Lett 328 (2002), 314-318.
19. C.A. McKenzie, J.S. Sinsheimer, A.A. Adeyemo, R.D. Cox, L. Southam, A. Hugill, N. Bouzekri, M. Lathrop, T.E. Forrester, R.S. Cooper and R. Ward, SNP haplotypes in the angiotensin I-converting enzyme (ACE) gene: analysis of Nigerian family data using gamete competition models, Ann Hum Genet 69 (2005), 227-232.
20. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
21. Y. Meng, C.T. Baldwin, A. Bowirrat, K. Waraska, R. Inzelberg, R.P. Friedland and L.A. Farrer, Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community, Am J Hum Genet 78 (2006), 871-877.
22. Y. Narain, A. Yip, T. Murphy, C. Brayne, D. Easton, J.G. Evans, J. Xuereb, N. Cairns, M.M. Esiri, R.A. Furlong and D.C. Rubinsztein, The ACE gene and Alzheimer's disease susceptibility In Process Citation, J Med Genet 37 (2000), 695-697.
23. J.P. O'Malley, C.L. Maslen and D.R. Illingworth, Angiotensin-converting enzyme and cardiovascular disease risk, Curr Opin Lipidol 10 (1999), 407-415.
24. R. Oba, A. Igarashi, M. Kamata, K. Nagata, S. Takano and H. Nakagawa, The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide, Eur J Neurosci 21 (2005), 733-740.
25. B. Palumbo, D. Cadini, G. Nocentini, E. Filipponi, M.L. Fravolini and U. Senin, Angiotensin converting enzyme deletion allele in different kinds of dementia disorders, Neurosci Lett 267 (1999), 97-100.
26. F. Richard, C. Berr, C. Amant, N. Helbecque, P. Amouyel and A. Alperovitch, Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline. The EVA Study Group, Neurobiol Aging 21 (2000), 75-80.
27. G.C. Roman, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, J.H. Garcia, L. Amaducci, J.M. Orgogozo, A. Brun and A. Hofman, Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop, Neurology 43 (1993), 250-260.
28. C. Rosendorff, M.S. Beeri and J.M. Silverman, Cardiovascular risk factors for Alzheimer's disease, Am J Geriatr Cardiol 16 (2007), 143-149.
29. J. Saxton, G. Ratcliff, A. Newman, S. Belle, L. Fried, J. Yee and L. Kuller, Cognitive test performance and presence of subclinical cardiovascular disease in the cardiovascular health study, Neuroepidemiology 19 (2000), 312-319.
30. F.A. Sayed-Tabatabaei, B.A. Oostra, A. Isaacs, C.M. van Duijn and J.C. Witteman, ACE polymorphisms, Circ Res 98 (2006), 1123-1133.
31. F. Soubrier, S. Martin, A. Alonso, S. Visvikis, L. Tiret, F. Matsuda, G.M. Lathrop and M. Farrall, High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity, Eur J Hum Genet 10 (2002), 553-561.
32. D.A. Tregouet, S. Barbaux, S. Escolano, N. Tahri, J.L. Golmard, L. Tiret and F. Cambien, Specific haplotypes of the P-selectin gene are associated with myocardial infarction, Hum Mol Genet 11 (2002), 2015-2023.
33. E. Villard, L. Tiret, S. Visvikis, R. Rakotovao, F. Cambien and F. Soubrier, Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis, Am J Hum Genet 58 (1996), 1268-1278.
34. X. Zhu, C.A. McKenzie, T. Forrester, D.A. Nickerson, U. Broeckel, H. Schunkert, A. Doering, H.J. Jacob, R.S. Cooper and M.J. Rieder, Localization of a small genomic region associated with elevated ACE, Am J Hum Genet 67 (2000), 1144-1153.